Prices of over-the-counter drugs used by 15-year-old adolescents in Germany and their association with socioeconomic background

Nutrient Supplements for Young Children and Mothers' Self Medication with Over-the-Counter Drugs During the COVID-19 Pandemic

BACKGROUND

The restriction of access to health services during the COVID-19 pandemic has led to an increase in self-medication. This study aims to examine mothers' use of nutrient supplements with over-the-counter (OTC) medications for their children, including instances of self-medication for themselves. The study also explores maternal characteristics associated with this behavior, the specific medications used, and the reasons for use.

METHOD

In this descriptive study, 450 mothers with children aged 2 to 6 years in Türkiye were recruited through social media platforms. Questions focused on whether mothers used supplements for themselves and their children, types of products, frequency, and reasons for use. Multivariable binary logistic regression was conducted to examine the factors associated with OTC medication use for children.

RESULT

Nearly half of the mothers reported administering OTC medications to their children. Factors associated with this practice included the child's age (specifically 48-72 months), attendance at nursery, perceived underweight status, and regular health visits with a pediatrician. Additionally, mothers who frequently used medications without a doctor's recommendation were 5.8 times more likely to give OTC drugs to their children. Maternal self-medication was significantly associated with an increased likelihood of OTC medication use for children (OR = 12.1). The most commonly used supplements included vitamin D, fish oil, multivitamins, vitamin C, immune boosters, zinc, probiotics, herbal teas, oral/nasal sprays, throat lozenges, and aspirin, with the primary purposes being prevention and treatment.

CONCLUSIONS

The administration of OTC medications in young children, who rely heavily on maternal care should be more closely monitored to ensure their safety and well-being, especially during epidemics.

Pediatric Outpatient Prescriptions in Countries With Advanced Economies in the 21st Century: A Systematic Review

Importance

An international comparison of pediatric outpatient prescriptions (POPs) is pivotal to investigate inadequate practices at the national scale and guide corrective actions.

Objective

To compare annual POP prevalence among Organisation for Economic Co-operation and Development (OECD) member countries.

Evidence Review

Two independent reviewers systematically searched PubMed, Embase, and institutes of public health or drug agency websites for studies published since 2000 and reporting POP prevalence (expressed as number of patients aged <20 years with ≥1 POP per 1000 pediatric patients per year) in OECD member countries or large geographic areas within them. Risk of bias was assessed for exhaustiveness and representativeness. Prevalence ratios (PRs) were used to compare the highest and lowest POP prevalence among countries overall, by levels of Anatomical Therapeutic Chemical (ATC) classification for the overall pediatric population, and by age group (ie, ages <5-6 vs ≥5-6 years), stratifying on prescription-only drug (POD) status.

Findings

Among 11 studies performed on 3 regional and 8 national medicoadministrative databases in 11 countries, 35 552 550 pediatric patients were included. The overall risk of bias was low (10 studies were representative [90.9%], and the prevalence denominator included nonusers of health care for 9 studies [81.8%]). Prevalence of 1 or more POP per year ranged from 480 to 857 pediatric patients per 1000 in Sweden and France, respectively (PR, 1.8 [95% CI, 1.8-1.8]). Overall, among 8 studies reporting ATC level 1 drugs, Denmark had the lowest POP prevalence (eg, systemic hormonal preparations: 9 pediatric patients per 1000 per year) and France the highest (eg, systemic hormonal preparation: 216 pediatric patients per 1000 per year). Among 8 studies reporting ATC level 2 drugs for PODs, the PR between France and Denmark was 108.2 (95% CI, 108.2-108.2) for systemic corticosteroids and 2.1 (95% CI, 2.1-2.1) for drugs for obstructive airway disease. The PR for antibiotics was 3.4 (95% CI, 3.4-3.4) between New Zealand and Sweden. For pediatric patients aged 5 to 6 years or older, the PR for sex hormones was 2.1 (95% CI, 2.1-2.1) between Denmark and France. Among 7 studies reporting ATC level 5 drugs, the prevalence of the 10 most prevalent PODs was less than 100 pediatric patients per 1000 per year in Scandinavian countries and the Netherlands and less than 300 pediatric patients per 1000 per year in France and New Zealand.

Conclusions and Relevance

This study found large between-country variations in POPs, which may suggest substantial inappropriate prescriptions. The findings may suggest guidance for educational campaigns and regulatory decisions in some OECD member countries.

The risk-value trade-off: price and brand information impact consumers' intentions to purchase OTC drugs

Background

European countries face fiscal pressure regarding the long-term sustainability of their healthcare system due to increasing levels of public health expenditures and mounting demographic pressures. The promotion of generic drugs is considered to be an efficient means to tackle these challenges; however, market diffusion remains slow. The aim of this study was to investigate the impact of price and brand cues on purchase intentions by means of Direct-to-Consumer (DTC) advertising, and to build on the market cue evaluation model by Dodd et al.

Methods

Participants rated purchase intentions on six DTC adverts varying in price and brand information, followed by self-reports on purchase intentions, attitudes towards generics, brand loyalty, price consciousness, as well as perceptions of quality, risk and value. Open-ended questions explored attitudes toward generic drugs.

Results

Brand information and purchase intentions were mediated by perceived risk and perceived quality, while price information influenced purchase intention through perceptions of quality, risk and value. Consumers’ purchase behaviour was furthermore  influenced by unawareness and misconceptions, past experiences, and advertising as a decision-making tool.

Conclusions

Advertisements, including price and brand information, are an important tool to improve consumers’ awareness of the availability of different OTC drugs. Practical and theoretical implications are discussed.